Topics
Glioblastoma | Treatment | Targeted therapy | Dasatinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Dasatinib
Breen WG, Dixon JG, Anderson SK,
Sarkaria JN, Brown PD, Yan ES, Kizilbash S, Galanis E, Anderson D,
Tran D, Mazurczak M, Johnson DR, Geoffroy FJ, Leinweber C, Laack
NN.
Final
Report on NCCTG N0877 (Alliance): A Phase II Randomized,
Placebo-Controlled Trial of Chemoradiotherapy with or without
Dasatinib for Glioblastoma.
Neuro
Oncol. 2025 Jun
28:noaf156. doi:
10.1093/neuonc/noaf156. PMID:
40579995. Interventional
study. ˍ